Capsular Polysaccharide of Group A Streptococcus

Area of Science:

• Microbiology
• Pathogenesis
• Biochemistry

Background:

• Streptococcus pyogenes possesses a hyaluronic acid capsule, a polymer of N-acetyl glucosamine and glucuronic acid.
• Capsule production varies among serotypes, with M18 strains producing abundant capsule (mucoid colonies) and M4/M22 strains producing none.
• Acapsular mutants show reduced virulence in animal models, indicating the capsule's importance.

Purpose of the Study:

• To summarize the biochemistry, genetics, regulation, and role in pathogenesis of the Streptococcus pyogenes hyaluronic acid capsule.
• To elucidate the mechanisms by which the capsule contributes to bacterial virulence.

Main Methods:

• Review of existing literature on Streptococcus pyogenes capsule.
• Analysis of studies involving acapsular mutant strains.
• Examination of bacterial-host cell interactions mediated by the capsule.

Main Results:

• The capsule confers resistance to complement-mediated opsonophagocytic killing by leukocytes, enhancing survival.
• The hyaluronic acid capsule can mask bacterial adhesins but also mediates attachment to host cells via CD44.
• Capsule binding to CD44 triggers signaling pathways that disrupt host cell junctions, facilitating invasion.

Conclusions:

• The hyaluronic acid capsule is a critical virulence factor for Streptococcus pyogenes.
• The capsule contributes to pathogenesis through immune evasion and promotion of bacterial invasion.
• Understanding the capsule's role is crucial for developing strategies against S. pyogenes infections.